PUBLISHER: The Business Research Company | PRODUCT CODE: 1989236
PUBLISHER: The Business Research Company | PRODUCT CODE: 1989236
The pharmaceutical label, serving as critical information attached to medication or drug products, contains vital details such as expiry dates, usage guidelines, and ingredient lists.
Primary types of pharmaceutical labels include pressure-sensitive, glue-applied, sleeve, in-mold labels, among others. Pressure-sensitive labels, employed in pharmaceutical, consumer goods, and similar packaging, utilize materials such as paper, polymer film, and more for instructional, decorative, functional, or promotional purposes. These labels cater to various end uses such as bottles, blister packs, parenteral containers, pre-fillable syringes, inhalers, pouches, and similar applications.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Tariffs impact the pharmaceutical label market by increasing the cost of importing label printing machinery, specialty inks, polymer films, adhesives, and advanced packaging components, leading to higher production costs for manufacturers. Regions heavily dependent on imported labeling materials such as North America, Europe, and Asia Pacific are significantly affected across pressure sensitive labels, polymer film labels, and tamper evident labeling segments. Higher tariffs may delay capacity expansion and increase pharmaceutical packaging costs. However, tariffs are also encouraging local manufacturing investments, supporting regional material sourcing, and helping build more resilient domestic pharmaceutical labeling ecosystems in the long term.
The pharmaceutical label market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical label market statistics, including pharmaceutical label industry global market size, regional shares, competitors with a pharmaceutical label market share, detailed pharmaceutical label market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical label industry. This pharmaceutical label market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pharmaceutical label market size has grown strongly in recent years. It will grow from $7.21 billion in 2025 to $7.82 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to growing pharmaceutical manufacturing activities, rising regulatory labeling requirements, increasing need for drug traceability, expanding prescription medication usage, strengthening focus on patient information safety.
The pharmaceutical label market size is expected to see strong growth in the next few years. It will grow to $11.13 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing demand for secure labeling technologies, rising adoption of smart connected labels, growing emphasis on sustainability in labeling materials, expansion of biologics and specialty drugs, strengthening regulatory compliance expectations. Major trends in the forecast period include increasing adoption of smart and digital pharmaceutical labels, rising demand for tamper evident and secure labeling solutions, growing shift toward sustainable and eco friendly label materials, expansion of high precision printing technologies in pharma labeling, strengthening emphasis on patient safety and regulatory compliance.
The expansion of the pharmaceutical industry is expected to support the growth of the pharmaceutical label market in the coming years. The pharmaceutical industry includes activities related to the research, development, manufacturing, and commercialization of medicinal drugs used to treat, prevent, or manage diseases and health conditions. Pharmaceutical labeling plays a crucial role in tracking and tracing products throughout the supply chain, ensuring timely distribution while minimizing the risk of counterfeit medicines entering the market. For example, in April 2025, data from Eurostat, a Luxembourg-based government agency, indicated that in 2024, exports of medicinal and pharmaceutical products from the European Union increased by 13.5% compared with 2023, reaching $316.38 billion (€313.4 billion). During the same period, imports rose only marginally by 0.5%, totaling $112.7 billion (€119.7 billion). Consequently, the growth of the pharmaceutical industry is driving the expansion of the pharmaceutical label market.
Leading companies operating in the pharmaceutical labeling market are focusing on the development of innovative solutions, such as AD XeroLinr DT, to improve sustainability and productivity. AD XeroLinr DT is a sustainable, linerless labeling solution designed for variable information (VI) applications. For instance, in March 2023, Avery Dennison, a US-based adhesive manufacturing company, introduced AD XeroLinr DT to help reduce overall logistics time and costs while setting new benchmarks for innovation, sustainability, and regeneration across the supply chain. AD XeroLinr DT delivers enhanced productivity, improved safety, and increased sustainability while maintaining the high performance and quality associated with Avery Dennison products. The solution is engineered to minimize waste and material usage, offering an efficient and environmentally responsible alternative for VI labeling. It is FSC-certified and phenol-free, reflecting the company's commitment to advancing sustainable practices within the packaging and labeling industry. The launch of AD XeroLinr DT highlights Avery Dennison's continued focus on innovation and sustainability in labeling solutions.
In August 2023, CCL Industries Inc., a Canada-based specialty labels and packaging manufacturer, acquired Faubel & Co. Nachfolger GmbH for $185.9 million. Through this acquisition, CCL Industries strengthened its presence in the global healthcare labeling market by expanding operational capabilities in Europe and enhancing its pharmaceutical clinical trials labeling portfolio. Faubel & Co. Nachfolger GmbH is a Germany-based specialty manufacturer that focuses on pharmaceutical clinical trial labels and advanced labeling solutions, including next-generation technologies such as RFID developed through its technology subsidiary.
Major companies operating in the pharmaceutical label market report are CCL Industries Inc., Essentra plc, Avery Dennison Corporation, Multi-Color Corporation, SATO Holding Corporation, LINTEC Corporation, Schreiner Group, Constantia Flexibles Group GmbH, Consolidated Label Co., Advanced Labels, Edwards Label Inc., Clabro Label Inc, Metro Label, WS Packaging Group Inc., Inland Label and Marketing Services LLC, MPI Label Systems Inc., Resource Label Group LLC, Smyth Companies LLC, The Kennedy Group Inc., Walle Corporation, Coast Label Company, Amcor Limited, Gerresheimer AG, Berry Global Inc.
North America was the largest region in the pharmaceutical label market in 2025. The regions covered in the pharmaceutical label market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pharmaceutical label market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The pharmaceutical label market consists of sales of drug facts labels and professional labeling. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pharmaceutical Label Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pharmaceutical label market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pharmaceutical label ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical label market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.